Dr. Joseph Tucker, CEO of Enveric Biosciences, details the Company’s plan to spin-off its #cannabinoid clinical development pipeline assets to a wholly-owned subsidiary, Acanna Therapeutics Inc. Following the spin-off, the…
Read More
Enveric is focused on creating a library of novel derivative molecules based on classic psychedelics.
